In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based diagnostics at Harvard’s Seidman Lab which allowed for targeted disease treatment ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 22, 2023 — For many patients with hypertension--an elevated blood pressure that can lead to stroke or heart ...
September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...
September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...
September 19, 2023 — A mathematical and computational model of the human heart entirely developed at Politecnico di ...
September 18, 2023 — Pregnant women with a history of substance abuse face a dramatically increased risk of death from ...
September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascu ...
September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...
September 14, 2023 — Myocardial infarction, the number one cause of sudden death in adults and the number two cause of ...
September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...
September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...
September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease t ...
In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...